retatrutide fda approval 2026 Tirzepatide vs. Is Retatrutide FDA Approved? Current

However, about 15% of users experience persistent symptoms beyond two weeks

In type 2 diabetes trials (the SUSTAIN program), Ozempic produced an average weight loss of around 4.5 kg to 6.5 kg (roughly 10 to 14 lbs) over 52 weeks, depending on the dose

The most realistic timeline places FDA approval in late next year, with commercial launch projected for early the year after

Temperature requirements Unopened vials belong in the refrigerator at 36 to 46 degrees Fahrenheit (2 to 8 degrees Celsius)

Your provider will tailor the plan by first confirming that you are an eligible candidate

Let's be blunt: shaking a peptide solution is like putting a delicate silk shirt in a washing machine with rocks